Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of VONASI versus Vocinti in healthy Thai volunteers under fasting conditions
TCTR20260605010Phase 1Not yet recruiting
- Sponsor
- T.O. Chemicals
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of vonoprazan (2 arms), sponsored by T.O. Chemicals. Primary endpoints: Maximum vonoprazan plasma concentration and Area under the time-concentration curve. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
vonoprazan
Beyond the preview
Go deeper on TCTR20260605010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260605010.